Press & news

FluoGuide develops surgical solutions that is expected to reduce suffering for the patient and increases the likelihood of cure as well as reducing costs for the health care system.

New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

New exchange: Nasdaq First North

Interview by Radio 24syv


April 29, 2019

Bodil Gantzel has invited Morten Albrechtsen to tell the story of FluoGuide and the forthcoming IPO. Listen to the program.